What does President Trump’s decision to leave the World Health Organization mean for public health? Should U.S. companies be intimidated by Chinese drug development? And
Will a contrarian leader be good for the Food and Drug Administration? Which ATTR-CM drug will have the best launch? And what are the hosts
What’s behind the “great abandonment” in gene therapy R&D? How does a startup spend $213 million? And is Adam an optimist? We talk about all
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And
Why has it taken so long for the world to get malaria vaccines? What relationship should drug companies have with patient advocates? And who in